Tomeika Ulett-Garcia
Adult Health · American Fork, UTNPI 1780027722
Payments from drug & device makers
Across 610 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$722
- Nestle Healthcare Nutrition Inc.$320
- Bristol Myers Squibb$254
- plus $2K from 20 others
What the payments were for
- Food & beverage$9,28898%
- Education$1762%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 249 | $4,063 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 91 | $1,145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 68 | $1,050 |
| Johnson & Johnson | 46 | $722 |
| Nestle Healthcare Nutrition Inc. | 23 | $320 |
| Bristol Myers Squibb | 20 | $254 |
| QOL Medical, LLC | 8 | $176 |
| Sanofi | 9 | $168 |
| Intercept Pharmaceuticals, Inc. | 10 | $166 |
| Redhill Biopharma Inc. | 8 | $158 |
| Daiichi Sankyo Inc. | 19 | $152 |
| Gilead | 7 | $147 |
| Ardelyx, Inc. | 5 | $132 |
| Organon | 9 | $122 |
| Pfizer | 7 | $121 |
| Boehringer Ingelheim | 5 | $108 |
| Braintree Laboratories, Inc. | 5 | $98 |
| Ferring Pharmaceuticals Inc. | 4 | $70 |
| Merck | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| Mylan Institutional Inc. | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Sandoz | 1 | $25 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| Evoke Pharma, Inc. | 1 | $12 |
How this compares
$9,464 in reported general payments places this provider in the 95th percentile of 53 adult health providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 29 | $131,316 |
| ZenpepLipase/Protease/Amylase | 14 | $49,894 |
| LinzessLinaclotide | 36 | $38,560 |
| XifaxanRifaximin | 12 | $36,285 |
| CreonLipase/Protease/Amylase | 13 | $23,676 |
| TrulancePlecanatide | 19 | $20,298 |
| Sucralfate | 47 | $5,290 |
| Rabeprazole Sodium | 74 | $4,110 |
| Pantoprazole Sodium | 208 | $3,367 |
| Omeprazole | 154 | $3,037 |
| Lubiprostone | 18 | $2,699 |
| Colestipol Hcl | 41 | $1,881 |
| Famotidine | 76 | $1,486 |
| Lactulose | 12 | $1,442 |
| Lansoprazole | 18 | $1,035 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor, Xifaxan, Trulance | $1,145 | $187,89860 claims |
| AbbVieLinzess, Creon | $4,063 | $62,23649 claims |
| Aimmune Therapeutics, Inc.Zenpep | $30 | $49,89414 claims |
| SandozLansoprazole | $25 | $1,03518 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 53 adult health providers in Utah.
Other adult health in American Fork
- Kristin LarsonSalt Lake City$75K
- Lucinda RossSalt Lake City$4K
- Deborah BartonSaint George$4K
- Rebecca WaiteVineyard$3K
- Jodi DawsonOgden$3K
- Joanne NamSalt Lake City$3K
- Irene CheongSalt Lake City$2K
- Emilee KellySt George$2K
- Brighton LovedayProvo$2K
- Peggy JeromeWest Jordan$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.